Chronic Pain Phenotypes in Older Adults: Mechanisms, Clinical Features, and Management Strategies

Abstract

Chronic pain is a prevalent and complex issue among older adults, manifesting in diverse phenotypes that have significant implications for clinical assessment and management. This review synthesizes recent scientific evidence on chronic pain phenotypes in the geriatric population, exploring epidemiology, pathophysiology, risk factors, clinical presentations, diagnostic strategies, and current as well as emerging therapeutic approaches. Emphasis is placed on mechanism-based understanding, multidisciplinary management, and guideline-driven care, addressing both nociceptive and neuropathic pain subtypes. The article aims to equip clinicians with practical, evidence-based insights for optimizing outcomes in older adults suffering from chronic pain.

Introduction

Chronic pain, defined as pain persisting beyond three months, is a major public health concern in older adults, adversely impacting functionality, psychological well-being, and quality of life. Distinct phenotypes—such as nociceptive, neuropathic, and mixed pain—present unique diagnostic and therapeutic challenges. The heterogeneity of pain syndromes in this demographic necessitates a nuanced, multidisciplinary approach, integrating mechanism-based assessments and individualized interventions. This review provides an in-depth analysis of chronic pain phenotypes in older adults, focusing on clinical relevance, underlying mechanisms, and evidence-based management strategies that align with current guidelines.

Epidemiology / Disease Burden

Chronic pain affects approximately 40–60% of adults over the age of 65, with prevalence increasing in institutionalized populations. Musculoskeletal pain—particularly in the back, hips, and knees—remains the most frequent, but neuropathic pain syndromes, such as postherpetic neuralgia and diabetic neuropathy, are also common. Chronic pain in older adults is associated with increased healthcare utilization, frailty, disability, depression, and cognitive decline, underscoring its substantial burden on individuals and health systems. Recent studies highlight disparities by sex, ethnicity, and socioeconomic status, indicating a need for tailored approaches in assessment and care.

Pathophysiology

The pathophysiology of chronic pain in older adults is multifactorial, involving peripheral and central mechanisms. Age-related changes in nociceptive processing include reduced density of peripheral nerve fibers, altered neurotransmitter function, and diminished endogenous pain inhibition. Nociceptive pain arises from tissue injury or inflammation, while neuropathic pain results from lesions or disease affecting the somatosensory system. Central sensitization, characterized by heightened responsiveness of nociceptive neurons, contributes to pain persistence and amplification. Comorbidities such as osteoarthritis, diabetes, and vascular disease further modulate pain processing, often resulting in complex, mixed pain states that challenge conventional classification and management.

Risk Factors

Key risk factors for chronic pain phenotypes in older adults include advanced age, female sex, genetic predisposition, lower socioeconomic status, obesity, sedentary lifestyle, and history of musculoskeletal injuries. Cognitive impairment, depression, and polypharmacy are also significant contributors, influencing both the perception and reporting of pain. Psychosocial factors—such as social isolation, low health literacy, and maladaptive coping strategies—further exacerbate the risk and severity of chronic pain, necessitating comprehensive biopsychosocial assessments in clinical practice.

Clinical Features

Older adults with chronic pain often present with overlapping symptoms, making clinical phenotyping essential for targeted management. Nociceptive pain typically manifests as aching, throbbing, or stiffness in weight-bearing joints or soft tissues. Neuropathic pain is characterized by burning, tingling, electric-shock-like sensations, and dysesthesia, often accompanied by allodynia or hyperalgesia. Mixed pain syndromes combine these features, complicating diagnosis and treatment. In addition to physical symptoms, chronic pain frequently co-occurs with sleep disturbances, mood disorders, cognitive decline, and functional impairment, underscoring the importance of holistic evaluation.

Diagnosis

Diagnosis of chronic pain phenotypes in older adults requires a systematic approach, involving detailed clinical history, standardized pain assessment tools (e.g., Brief Pain Inventory, Neuropathic Pain Questionnaire), and thorough physical examination. Distinguishing between nociceptive, neuropathic, and mixed pain is critical, as it guides therapeutic decisions. Laboratory tests and imaging studies may be warranted to identify underlying etiologies, such as osteoarthritis or nerve compression. Multidimensional assessment—including functional status, psychosocial factors, and comorbidities—is vital for developing individualized management plans. Emerging biomarkers and quantitative sensory testing hold promise for future phenotypic categorization.

Treatment & Management

Management of chronic pain in older adults should be multimodal and tailored to the identified phenotype. Non-pharmacological interventions—such as physical therapy, cognitive-behavioral therapy, and exercise—form the cornerstone of treatment, with robust evidence supporting their efficacy and safety. Pharmacologic options include acetaminophen, topical NSAIDs, and low-dose antidepressants or anticonvulsants for neuropathic pain. Opioids should be reserved for refractory cases, given heightened risk of adverse effects. Interventional approaches (e.g., nerve blocks, intra-articular injections) may benefit select patients. Multidisciplinary pain programs, involving physicians, physical therapists, psychologists, and social workers, optimize outcomes and reduce reliance on medications.

Recent Advances / Emerging Therapies

Recent advances in the management of chronic pain phenotypes in older adults include neuromodulation techniques (e.g., spinal cord stimulation, transcutaneous electrical nerve stimulation), novel pharmacotherapies targeting specific pain pathways (e.g., N-type calcium channel blockers, monoclonal antibodies against nerve growth factor), and digital health interventions (e.g., tele-rehabilitation, pain self-management apps). Personalized medicine approaches—leveraging genetic, neuroimaging, and proteomic data—are being explored to refine phenotypic classification and predict treatment response. Ongoing trials are evaluating the safety and efficacy of cannabinoids and other emerging agents in geriatric populations.

Guideline Recommendations

Current guidelines from organizations such as the American Geriatrics Society and the European Pain Federation emphasize comprehensive assessment, prioritization of non-pharmacological treatments, cautious use of medications, and regular monitoring for adverse effects. Individualized care plans—incorporating patient preferences, functional goals, and comorbidities—are recommended. Multidisciplinary collaboration and patient education are essential for optimizing adherence and outcomes. Guidelines also call for ongoing research to address knowledge gaps in phenotypic classification, treatment efficacy, and long-term safety in older adults.

Conclusion

Chronic pain phenotypes in older adults represent a heterogeneous and clinically significant challenge. Mechanism-based understanding, comprehensive assessment, and individualized multimodal interventions are essential for optimal management. Recent advances offer new avenues for personalized care, but further research is needed to refine phenotypic classification and improve outcomes. Clinicians must remain vigilant in applying guideline-driven practices, prioritizing safety, function, and quality of life in this vulnerable population.